|
⚲
|
| Keyboard |
| Vida Ventures LLC
✚
|
|
|---|---|
| CIK # | 0001905615, 0001724489 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001724489] | |
| 4 | [0001724489] | |
| D | [0001724489] | |
| SC 13D | [0001724489] | |
| SC 13G | [0001724489] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Vida Ventures LLC | Kyverna Therapeutics Inc | [2024-05-03] |
| Vida Ventures LLC | Praxis Precision Medicines Inc | [2021-02-16] |
| Vida Ventures LLC | Kinnate Biopharma Inc | [2021-02-16] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Vida Ventures III-A LP | |
| Kyverna Therapeutics Inc | |
| Vida Ventures GP III LLC | |
| Vida Ventures III LP | |
| Vida Ventures LLC | |
| Oyster Point Pharma Inc | |
| VV Manager LLC | |
| Q32 Bio Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Kyverna Therapeutics Inc KYTX
Series B Redeemable Convertible Preferred Stock · derivative
|
2024-02-12 | Conversion | 7,356,162 | $0.00 | |
|
Kyverna Therapeutics Inc KYTX
Series A-1 Redeemable Convertible Preferred Stock · derivative
|
2024-02-12 | Conversion | 4,401,771 | $0.00 | |
|
Kyverna Therapeutics Inc KYTX
Series A-2 Redeemable Convertible Preferred Stock · derivative
|
2024-02-12 | Conversion | 8,830,901 | $0.00 | |
|
Kyverna Therapeutics Inc KYTX
Common Stock
|
2024-02-12 | Conversion | 4,523,924 | ||
|
Kyverna Therapeutics Inc KYTX
Common Stock
|
2024-02-12 | Buy | 252,553 | $22.00 | 5,556,166 |
|
Kyverna Therapeutics Inc KYTX
Common Stock
|
2024-02-12 | Buy | 583 | $22.00 | 12,826 |
|
Oyster Point Pharma Inc OYST
Series B Convertible Preferred Stock · derivative
|
2019-11-04 | Conversion | 778,468 | ||
|
Oyster Point Pharma Inc OYST
Common Stock, par value $0.001 per share
|
2019-11-04 | Buy | 185,000 | $16.00 | 2,960,000 |
|
Oyster Point Pharma Inc OYST
Common Stock, par value $0.001 per share
|
2019-11-04 | Conversion | 778,468 | ||
|
Q32 Bio Inc FIXX
Common Stock
|
2018-04-02 | Conversion | 395,845 | $0.00 | |
|
Q32 Bio Inc FIXX
Series B Preferred Stock · derivative
|
2018-04-02 | Conversion | 395,845 | $0.00 | |
|
Q32 Bio Inc FIXX
Common Stock
|
2018-04-02 | Buy | 375,000 | $16.00 | 6,000,000 |